Demi Dorrepaal

Demi Dorrepaal is an active researcher in the Department of Pediatrics at Erasmus University Medical Center, specializing in growth disorders and metabolic outcomes in pediatric populations. Her research focuses on children born small for gestational age, bone mineral density development, and the long-term effects of growth hormone treatment.

Her research interests center on body composition analysis, particularly examining bone density development in preterm and term-born children through techniques like dual-energy X-ray absorptiometry. She investigates how factors including growth hormone therapy, nutritional status, and environmental exposures (such as PFAS) impact growth trajectories and metabolic health outcomes from infancy through adulthood. A significant portion of her work follows patients long-term to assess quality of life and neurological outcomes after cessation of childhood growth hormone treatment.

Analysis of her recent publications reveals a strong trend toward longitudinal studies examining bone health markers across developmental stages, with increasing focus on environmental influences on growth parameters. Her work consistently bridges clinical endocrinology with nutritional science and environmental health.

Demi Dorrepaal collaborates extensively with the research group led by Hokken-Koelega AC S, contributing to multiple high-impact publications in journals like Clinical Nutrition and The Journal of Clinical Endocrinology and Metabolism. Her research demonstrates methodological rigor through the use of prospective cohort designs and comprehensive outcome assessments.